ClinicalTrials.gg
Drug

Afatinib clinical trials

Also written BIBW 2992, Giotrif, Gilotrif and (2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate).

studies test it
160
open now
15
in phase 3
17
first study started
2003

How each study uses Afatinib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Afatinib studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
12 Jul 2013 · GILOTRIF · NDA 201292 (FDA, Drugs@FDA)
European Union
25 Sept 2013 · Giotrif · EMEA/H/C/002280 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Afatinib
85
Afatinib Dimaleate
7
BIBW 2992MA2
4
Afatinib 40 MG
3
BIBW 2992 (Afatinib)
3

Brand

Giotrif
15
Gilotrif
15

Development codes

BIBW 2992
52

Other names

(2E)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((3S)-tetrahydrofuran-3-yl)oxy)quinazolin- 6-yl)-4-(dimethylamino)but-2-enamide bis(hydrogen (2Z)-but-2-enedioate)
3

Studies by the year they started

160 studies that test it; most in 2015 (17)

Studies that test Afatinib, by start year
YearStudies
20031
20044
20052
20065
20075
20087
200910
20108
201111
201214
201312
20147
201517
201611
20177
20187
20193
20206
20215
20224
20233
20247
20253
20261

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
53
Phase 2
93
Phase 3
17
Phase 4
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 66 · Other 94

Boehringer Ingelheim (65) · West China Hospital (4) · Massachusetts General Hospital (4) · National Cancer Institute (NCI) (3) · European Organisation for Research and Treatment of Cancer - EORTC (3) · The Netherlands Cancer Institute (3) · Yonsei University (3) · H. Lee Moffitt Cancer Center and Research Institute (2)

Often tested with

Tested in the same studies.

Palbociclib (6) · Nintedanib (5) · Pembrolizumab (4) · Paclitaxel (4) · Dasatinib (3) · Nivolumab (3) · Osimertinib (3) · Cetuximab (3)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7

Studies that test Afatinib.

Studies

Open first, then newest update. How each study uses Afatinib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 160

See all 160 studies that test Afatinib →

Given beside what is tested · 22 — Afatinib is usual care or a partner of the new treatment

Showing 20 of 22.

As the comparator · 1 — what is tested is compared with Afatinib

Codes

What other systems call Afatinib · ClinicalTrials.gg INT006789

  • MeSH (NLM) D000077716AfatinibConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 41UD74L59MAFATINIBConfirmed FDA, NLM, Wikidata
  • RxNorm 1430438Confirmed FDA, Wikidata
  • Wikidata Q4688818afatinibConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C66940AfatinibOne source FDA
  • DrugBank DB08916One source Wikidata

Also registered as afatinib dimaleate (UNII V1T5K7RZ0B · RxNorm 1430441).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.